HCC tumors can upregulate the expression of Programmed Death Ligand 1 (PD-L1), which then interacts with Programmed Death Protein 1 (PD-1) on T cells, effectively suppressing the immune response. This evidence concerns the gene CD274 and hepatocellular carcinoma.